Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL36AP15 is a processed pseudogene located in the human genome that shares sequence similarity with the ribosomal protein L36a gene (RPL36A) but does not produce a functional ribosomal protein[2][8][11][13][14]. While the parent gene (RPL36A) encodes a component of the 60S ribosomal subunit and is involved in protein synthesis, RPL36AP15 is classified as a pseudogene and is not known to fulfill any protein-coding or receptor function. Pseudogenes like RPL36AP15 may have regulatory roles in gene expression in some biological contexts, by mechanisms such as serving as miRNA sponges or producing non-coding RNAs that influence their parent gene, but specific regulatory functions for RPL36AP15 are not reported in current literature[5][11]. RPL36AP15 is not a therapeutic target, not directly involved in disease pathogenesis, and has no known pharmacological or clinical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 15 (RPL36AP15).